Javascript must be enabled to continue!
Abstract 1651: Regulation of omental seeding of ovarian cancer cells by SPARC.
View through CrossRef
Abstract
Epithelial Ovarian cancer is the leading cause of death from malignant gynecologic tumors, as most patients have extensive late metastatic disease at the time of diagnosis. Ovarian cancer (OvCa) cells have specific predilection to metastasize to omentum, a condition known as “peritoneal ovarian carcinomatosis, POC” but rarely leave the peritoneal cavity. Despite aggressive surgical debulking and cytoreduction, recurrence of omental implants is high with poor patient survival. We have recently reported that the tumor suppressor role of matricellular glycoprotein SPARC (secreted protein acidic and rich in cysteine) in POC through differential effects on OvCa cells and their interactions with components of the peritoneal microenvironment. Given that SPARC is the first known matricellular protein involved in adipose tissues homeostasis, we sought to elucidate the potential roles of SPARC on the omental adipocyte-OvCa cells cross-talk and its impact on POC, in vivo and in vitro. Using primary omental SP−/− and SP+/+ omental stromal cells, we found that adipocyte-SPARC delayed the adipogenic differentiation of omental stromal cells. SP−/- omental adipocytes expressed significantly higher levels of adipogeneic markers and accumulated significantly less oil droplets than SP+/+. Primary SP−/− adipocytes promoted homing of ID8 murine OvCa cells to the omentum in vivo and their migration and invasion in 3D-cocultures in vitro. Mechanistic studies using human and murine adipocyte-OvCa genetically manipulated for SPARC expression in 3D co-cultures, revealed that the effect of SPARC suppressing adipocyte-OvCa cell cross-talk mediated by the effect suppressing the activation of cEBP-β, NFκB and AP-1 in OvCa cells as well as in adipocytes with subsequent decrease in chemokines/adipokines as well as fatty acid exchange between OvCa cells and adipocytes. Our data indicates the metastasis suppressor effect of SPARC in POC is mediated in part via inhibiting the key transcription factors involved in adipocytes differentiation and OvCa progression identifying SPARC as a potential inhibitor of OvCa cell omental seeding and dormancy.
Citation Format: Dylan P. Matthews, Neveen A. Said. Regulation of omental seeding of ovarian cancer cells by SPARC. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1651. doi:10.1158/1538-7445.AM2013-1651
American Association for Cancer Research (AACR)
Title: Abstract 1651: Regulation of omental seeding of ovarian cancer cells by SPARC.
Description:
Abstract
Epithelial Ovarian cancer is the leading cause of death from malignant gynecologic tumors, as most patients have extensive late metastatic disease at the time of diagnosis.
Ovarian cancer (OvCa) cells have specific predilection to metastasize to omentum, a condition known as “peritoneal ovarian carcinomatosis, POC” but rarely leave the peritoneal cavity.
Despite aggressive surgical debulking and cytoreduction, recurrence of omental implants is high with poor patient survival.
We have recently reported that the tumor suppressor role of matricellular glycoprotein SPARC (secreted protein acidic and rich in cysteine) in POC through differential effects on OvCa cells and their interactions with components of the peritoneal microenvironment.
Given that SPARC is the first known matricellular protein involved in adipose tissues homeostasis, we sought to elucidate the potential roles of SPARC on the omental adipocyte-OvCa cells cross-talk and its impact on POC, in vivo and in vitro.
Using primary omental SP−/− and SP+/+ omental stromal cells, we found that adipocyte-SPARC delayed the adipogenic differentiation of omental stromal cells.
SP−/- omental adipocytes expressed significantly higher levels of adipogeneic markers and accumulated significantly less oil droplets than SP+/+.
Primary SP−/− adipocytes promoted homing of ID8 murine OvCa cells to the omentum in vivo and their migration and invasion in 3D-cocultures in vitro.
Mechanistic studies using human and murine adipocyte-OvCa genetically manipulated for SPARC expression in 3D co-cultures, revealed that the effect of SPARC suppressing adipocyte-OvCa cell cross-talk mediated by the effect suppressing the activation of cEBP-β, NFκB and AP-1 in OvCa cells as well as in adipocytes with subsequent decrease in chemokines/adipokines as well as fatty acid exchange between OvCa cells and adipocytes.
Our data indicates the metastasis suppressor effect of SPARC in POC is mediated in part via inhibiting the key transcription factors involved in adipocytes differentiation and OvCa progression identifying SPARC as a potential inhibitor of OvCa cell omental seeding and dormancy.
Citation Format: Dylan P.
Matthews, Neveen A.
Said.
Regulation of omental seeding of ovarian cancer cells by SPARC.
[abstract].
In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC.
Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 1651.
doi:10.
1158/1538-7445.
AM2013-1651.
Related Results
Abstract POSTER-BIOL-1344: Epigenetic regulation of SPARC in ovarian cancer
Abstract POSTER-BIOL-1344: Epigenetic regulation of SPARC in ovarian cancer
Abstract
Background: We have previously reported the tumor suppressor effect of Secreted protein acidic and rich in cysteine (SPARC) in ovarian cancer in vitro and i...
SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity
SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity
Abstract
Purpose
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and lacks specific targeted ...
Correlation of SPARC, ER, PR, and HER2 tumor with progression-free survival from a phase II neoadjuvant trial of gemcitabine, epirubicin, and nab-paclitaxel
Correlation of SPARC, ER, PR, and HER2 tumor with progression-free survival from a phase II neoadjuvant trial of gemcitabine, epirubicin, and nab-paclitaxel
618 Background: Neoadjuvant combinations of gemcitabine (G), anthracyclines and taxanes have demonstrated substantial activity with pCR rates of 20–25%. Secreted protein acidic ri...
KnowMore: an automated knowledge discovery tool for the FAIR SPARC datasets
KnowMore: an automated knowledge discovery tool for the FAIR SPARC datasets
Abstract
This manuscript provides the methods and outcomes of KnowMore, the Grand Prize winning automated knowledge discovery tool developed by o...
Abstract 1654: Cisplatin resistance is associated with autophagy in SPARC expressing medulloblastoma cells.
Abstract 1654: Cisplatin resistance is associated with autophagy in SPARC expressing medulloblastoma cells.
Abstract
Medulloblastoma is the most common malignant brain tumor in children and is associated with a poor outcome. Our previous studies indicate that SPARC express...
KnowMore: an automated knowledge discovery tool for the FAIR SPARC datasets
KnowMore: an automated knowledge discovery tool for the FAIR SPARC datasets
Background:
This manuscript provides the methods and outcomes of KnowMore, the Grand Prize winning automated knowledge discovery tool developed by our team duri...
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
<div>Abstract<p>SPARC is an extracellular matrix protein that exerts pleiotropic effects on extracellular matrix organization, growth factor availability, cell adhesion...
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
Data from Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC
<div>Abstract<p>SPARC is an extracellular matrix protein that exerts pleiotropic effects on extracellular matrix organization, growth factor availability, cell adhesion...

